Purchase Order HHSN275201600922P
Award Date 9/22/16
Potential Completion Date 9/21/17
Potential Value $174K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $116,700.00 firm fixed price purchase order was awarded to Pine Pharmaceuticals LLC, a for-profit limited liability company, by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations. The contract has a completion date of August 17, 2023 and does not have a set-aside designation. Based on the information provided, Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that has previously provided pharmaceutical...
- This is a $81,714.96 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of intravenous stable isotope glucose (D5 glycerol) to support metabolic research. The contract has an ultimate completion date of April 30,...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a delivery order valued at $69,466.32 to Pine Pharmaceuticals LLC on August 14, 2025, for the provision of intravenous stable isotope glucose (6,6 deuterated glucose) to support metabolic research initiatives. This non-severable delivery order, structured as a firm fixed-price contract, is scheduled for completion by May 31, 2026, with performance taking place at Pine Pharmaceuticals' facility in Tonawanda, New York. No...
- This is a federal delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company. The $158,877.60 firm fixed price contract is for the provision of metabolic isotopes, a non-severable service, with a performance period ending on April 13, 2026. Pine Pharmaceuticals is an FDA-registered 503B outsourcing...
- This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope (6,6 D2-Glucose) for metabolic research. The $138,712.14 contract has an ultimate completion date of November 2, 2024 and was awarded on a sole-source basis without a small business set-aside. Pine Pharmaceuticals is an...
- This is a firm-fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the procurement of 6,6 D2-glucose 72.9 mg/ml (30 ml) vials, which are likely being used to support metabolic research studies conducted by NICHD. The contract has a ceiling value of $12,371.12 and a period of...
- This is a $125,812.80 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the acquisition of intravenous stable isotopes, specifically 6,6 deuterated glucose and d5 glycerol, to support metabolic research conducted by NIDDK. The contract was awarded on a non-competitive, sole-source basis, as Pine Pharmaceuticals is the only approved...
- This is a $20,600 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the Department of Health and Human Services, to Enamine US Inc., a small business contractor. The contract is for single-cell RNA sequencing analysis to investigate the role of GPR110 in cell-type specific neurogenesis. This award supports the NIAAA's mission in advancing translational science and developing prevention and treatment strategies...
- This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Pharmaron, Inc., a global contract research organization. The $281,751.22 purchase order contract is for a firm fixed price and does not have a set-aside designation. Under this contract, Pharmaron is conducting a variety of drug development activities to support the work of the NIH's National Center for Advancing Translational Sciences...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed price purchase order valued at $18,302.40 to Life Technologies Corporation. Under this contract, Life Technologies will provide NIAAA with supplies consisting of an 8-plex mouse proteome panel to support alcohol-related research efforts. Performance will take place in Grand Island, New York over a one...